E2F6 and ovarian cancer: Additionally, our study revealed that E2F6 was up-regulated in ovarian cancer and functions as a direct target of miR-454.The findings of the present study not only provide a new insight into the mechanism of ovarian cancer development but also suggest that the miR-454 may be a potential diagnostic biomarker and therapeutic target for ovarian cancer.